Sentry Investment Management LLC grew its stake in shares of Mylan (NASDAQ:MYL) by 24.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 42,612 shares of the company’s stock after acquiring an additional 8,322 shares during the quarter. Sentry Investment Management LLC’s holdings in Mylan were worth $1,803,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds also recently bought and sold shares of MYL. Meeder Asset Management Inc. boosted its position in Mylan by 76.9% in the third quarter. Meeder Asset Management Inc. now owns 3,393 shares of the company’s stock valued at $106,000 after buying an additional 1,475 shares during the last quarter. BT Investment Management Ltd purchased a new stake in Mylan in the third quarter valued at approximately $142,000. Advisor Partners LLC purchased a new stake in Mylan in the fourth quarter valued at approximately $214,000. First Personal Financial Services boosted its position in Mylan by 77.1% in the fourth quarter. First Personal Financial Services now owns 4,839 shares of the company’s stock valued at $205,000 after buying an additional 2,106 shares during the last quarter. Finally, Mycio Wealth Partners LLC purchased a new stake in Mylan in the fourth quarter valued at approximately $212,000. Hedge funds and other institutional investors own 75.56% of the company’s stock.
In other Mylan news, CEO Heather M. Bresch sold 75,000 shares of the company’s stock in a transaction that occurred on Tuesday, January 9th. The stock was sold at an average price of $45.00, for a total value of $3,375,000.00. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 0.69% of the company’s stock.
A number of equities research analysts recently commented on the company. Goldman Sachs Group upped their target price on Mylan from $46.00 to $52.00 and gave the company a “buy” rating in a research report on Thursday, January 11th. TheStreet lowered Mylan from a “b-” rating to a “c+” rating in a research report on Friday. Royal Bank of Canada upped their target price on Mylan from $32.00 to $37.00 and gave the company a “sector perform” rating in a research report on Tuesday, November 7th. Leerink Swann assumed coverage on Mylan in a research report on Tuesday, January 2nd. They issued a “market perform” rating and a $44.00 target price on the stock. Finally, Citigroup reiterated a “buy” rating and issued a $58.00 target price (up previously from $48.00) on shares of Mylan in a research report on Thursday, January 4th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have issued a buy rating to the stock. Mylan presently has a consensus rating of “Buy” and an average target price of $44.65.
Shares of Mylan (NASDAQ:MYL) opened at $40.60 on Tuesday. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.46 and a quick ratio of 0.95. Mylan has a 52-week low of $29.39 and a 52-week high of $47.82. The company has a market capitalization of $21,071.22, a P/E ratio of 25.22, a price-to-earnings-growth ratio of 1.06 and a beta of 1.35.
ILLEGAL ACTIVITY WARNING: This piece of content was originally reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was stolen and republished in violation of international trademark & copyright legislation. The legal version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/13/mylan-myl-stake-boosted-by-sentry-investment-management-llc.html.
Mylan Company Profile
Mylan N.V. is a global pharmaceutical company. The Company develops, licenses, manufactures, markets and distributes generic and branded generic products for resale by others; specialty pharmaceuticals, and active pharmaceutical ingredients (APIs). It operates through two segments: Generics and Specialty.
Want to see what other hedge funds are holding MYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mylan (NASDAQ:MYL).
Receive News & Ratings for Mylan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mylan and related companies with MarketBeat.com's FREE daily email newsletter.